Rapid and Simple Isolation of Circulating Tumor Cells for Clinical and Research Applications Using ScreenCell ®

PMID :

ScreenCell FCD kit

Abstract

Circulating tumor cells (CTCs) are malignant cells shed by the primary tumor or metastases into the peripheral circulation. CTCs give rise to distant metastases that are usually the ultimate cause of cancer-related death. A significant proportion of patients with early stage cancer in whom no metastases are identifiable will ultimately relapse as a result of hematogenous spread of tumor cells that were undetected at initial diagnosis and treatment.

Mots clés

Partager sur

Navigation

Quel kit correspond à mon application ?

Les derniers articles.

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus – Cytomorphological Heterogeneity

Pour l'amélioration de la
prise en charge des patients
grâce à l'analyse des CTC

Webinaire

Circulating Tumor Cell Analysis :
a new workflow combining ScreenCell® Technology
with Stilla Crystal Digital PCR®

Mardi 8 avril 2025
04:00 PM CET
Mercredi 9 avril 2025
03:00 PM CST